Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
Published May 24, 2023 · Recall initiated: May 9, 2023
Summary
FDA records drug Class II recall D-0579-2023, published May 24, 2023 and initiated May 9, 2023. Recalling firm: B. Braun Medical Inc; Status: Terminated; Reported quantity: 1,380; Lot: Lot Number: J1P154N, Exp: 31 May, 2023,. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent: Low anti-factor IIa Potency.
What to do
Voluntary: Firm initiated · Letter
Get an email if HEPARIN SODIUM IN DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HEPARIN SODIUM IN DEXTROSE
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot Number: J1P154N, Exp: 31 May, 2023,
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD box, NDC #May 24, 2023
- FDAAmpicillin for Injection, USP 250 mg per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017May 24, 2023
- FDAKetotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045, RepackagedMay 24, 2023
- FDAAmpicillin for Injection, USP 500 mg per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017May 24, 2023
- FDAHeparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL ExcelMarch 15, 2023
- FDAHeparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCELJune 19, 2019
Questions about this recall
Was Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20, recalled?
Yes. FDA published recall D-0579-2023 on May 24, 2023. Reported hazard: Subpotent: Low anti-factor IIa Potency.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HEPARIN SODIUM IN DEXTROSE.